Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional

Name: Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional
Brand: Springer Nature
SKU: 9781461436829
Availability: InStock

Best Price (Coupon Required):
Buy Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional for $45.00 at @ Link.springer.com when you apply the 10% OFF coupon at checkout.
Click “Get Coupon & Buy” to copy the code and unlock the deal.

Set a price drop alert to never miss an offer.

1 Offer Price Range: $49.99 - $49.99

BEST PRICE

Single Product Purchase

$45.00

@ Link.springer.com with extra coupon

Price Comparison

Seller	Contact Seller	List Price	On Sale	Shipping	Best Promo	Final Price	Volume Discount	Financing	Availability	Seller's Page
BEST PRICE 1 Product Purchase @ Link.springer.com		$49.99	$49.99		10% OFF This deals requires coupon	$45.00		See Site	In stock	Visit Store

Product Details

Brand

Springer Nature

Manufacturer

N/A

Part Number

GTIN

9781461436829

Condition

New

Product Description

This Brief defines competitive intelligence (CI) as a tool for making investment decisions within the pharmaceutical industry.It provides an overview of processes that the regulatory affairs professional must take into account when evaluating data impacting product-based risk evaluations. These apply particularly to evaluations that focus on outputs such as regulatory approval, or the commercial impact of product labeling on the sales forecast over a limited timeframe. The Brief also provides an overview of intellectual property assessment that can impact a products lifespan on the market due to patent protection itself (or loss of patent protection) or via regulatory exclusivity. Case examples are discussed to illustrate theimportance of keeping up with the ever-changing regulations, andhow to interpret them in the context ofCI. In addition, there is a section on virtual data rooms (VDRs) which currently function as the cornerstone of due diligence investigations. While aimed primarily at regulatory affairs professionals in the United States, this publication provides a useful adjunct for other pharmaceutical executives, especially those new to product-based investments, and regulatory affairs professionals in other regions.

Available Colors

N/A

Available Sizes

N/A